Information filters

  • TIES®
  • Corporate
  • Job postings
  • Articles
  • Patients
  • General

The TIES® System represented at major political event

The TIES® Implant and Lid will be represented at Almedalsveckan, an annual political event taking place in Visby, Sweden between the 3rd and 10th of July this year. The Swedish research institute, Swerea will display the solution as an outstanding example of the possibilities using revolutionary 3D manufacturing technology towards patients. OstomyCure has collaborated with Swerea regarding high quality testing of the TIES® System, to ensure safety for the patients.

First Patients enrolled in the C03 clinical study in the UK

2019-06-09

Today the first patient was enrolled in the TIES03 study of the OstomyCure Transcuteous Implant Evacuation System (TIES®). A 64-year-old female from the UK had the TIES port successfully implanted in a procedure that took less than an hour with no complications.

OstomyCure® AS receives the most sought-after Horizon 2020 EU grant of € 2.5 Mio.

2019-02-20

OstomyCure AS® has received a EU grant of € 2.5 Mio. via the Horizon 2020 Project.

Large clinical study started in UK and Sweden

2018-06-05

Approval for multicenter study “TIES-C03” in major university hospitals in Leeds, UK & Umeå, Sweden. OstomyCure AS has achieved an important milestone on the way to making the revolutionary TIES® Solution available to ileostomy patients, a patient population that has not experienced any meaningful improvements in “standard of care” in the last 30-40 years. The study aims to gather more and longer term clinical data regarding safety, performance and Quality of Life. The study has started at Norrland University Hospital, Umeå, Sweden with Associate Professor Karin Strigård and Prof. Ulf Gunnarsson and at St. James Hospital, Leeds with Professor David Jayne as the main investigators. OstomyCure plans to commit additional clinical centers (primarily in the UK) to participate in the “TIES-C03” study.

Latest update on TIES Solution

2018-01-11

Message from CEO Ostomycure Dr Benedict Broenniman M.D.

OstomyCure AS Appoints new Chief Medical Officer

2017-01-31

OstomyCure today announced the appointment of Cindy Wong, M.D. as Chief Medical Officer (CMO).

Article in IA Journal: Issue 233 Autumn 2016

2016-11-10

OstomyCure AS has been published in The Ileostomy & Internal Pouch Support Groups latest issue of the IA Journal.

Experienced Chief Commercial Officer Joins OstomyCure AS

2016-09-26

OstomyCure AS engages Morten Gunvad, currently founder and Head of GP Consulting GmbH, as Chief Commercial Officer of the TIES® System.

Significant Breakthrough for Stoma Patients

2016-06-20

Aimed to dramatically improve the patient’s quality of life, the TIES® System, a new concept in continent ileostomy receives CE marking.

CE-marking for the TIES® System

2016-06-10

Today, OstomyCure is very pleased to announce that the TIES® System has received approval for CE marking from our Notified Body.